Meds Update Resource Page

medicinesMedication Updates 2017

Feeling overwhelmed by all the new recently approved diabetes medications? Concentrated insulins are causing confusion and the first bio-similiar insulin was recently approved. There are 2 new insulin + GLP-RA combo medications on the market and a new oral combo medication was just approved.

Are you wondering how to apply the new ADA and AACE Medication Management Guidelines into practice?

We have lots of resources to help out!

Medication Update 2017 – 1.5 CEs – Online University course

This course is included in: Medication Update ToolkitPurchase this course individually for $29 or the entire bundle and save 50%. 

There is an abundance of new medications approved by the FDA. In addition, there are new important warnings on older medications. Concentrated insulins are causing confusion and the first biosimiliar insulin was recently approved. There are 2 new insulin +GLP-RA combo medications on the market.  

 


Online University Courses

 GabeFriedmanPhoto-2302New Updated Medication PocketCard

Download our CDE Coach App for free pocketcard updates


  Articles on Diabetes Medications

§ADA-Standards of Care PDF 2017 – This yearly publication by the American Diabetes Association outlines the goals of care for diabetes management. Since it is evidenced based, it includes a useful summary of the trials and research that the goals are based on. A must read if you are entering the diabetes field or preparing to take the CDE® or BC-ADM Exam.

Pharmacologic Approaches to Glycemic Treatment.  This hyperglycemia road map details strategies to achieve glucose control for both Type 1 and Type 2 Diabetes. Section 8 of Standards of Care, Jan 2017. 

§ AACE Comprehensive Diabetes Management Algorithm 2016. A slide set summary of the ACE/AACE Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus.  Encourage all those planning to take CDE® exam to review this info carefully.

§ AACE – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2016 A comprehensive care plan for people with diabetes, published by the American Association of Clinical Endocrinologists and American College of Endocrinology.

AADE – White Paper on Continuous Subcutaneous Insulin Therapy » This paper outlines the topics that should be covered by diabetes educators when teaching patients and families or significant others about insulin pump therapy

AADE – Strategies for InsulinTherapy 2011.PDF » An excellent review of the latest research on proper insulin administration techniques, patient barriers and insulin therapy.

Beyond Metformin: Safety Considerations in the Decision Making Process for Selecting a Second Medication for Type 2 Diabetes Management » This expert opinion article outlines the latest data on the safety and other considerations for currently available medications to treat type 2 diabetes. Published in Diabetes Care, 2014

Consumer Report’s Best Buy Drugs » it offers a fresh look at diabetes medication from a consumer perspective.Diabetes treatment: Insulin and incretins – Fowler, M. (2010). Clinical Diabetes – An excellent review of the latest in insulin therapy.

Diabetes Meds on a Budget – 2017 » This article by Beverly Thomassian, provides practical and affordable strategies to manage hyperglycemia when funds are limited.

Novel Agents for the Treatment of Type 2 – 2014 – Diabetes Spectrum » Recent innovative treatment approaches target the multiple pathophysiological defects present in type 2 diabetes. Optimal management should include early initiation of combination therapy using multiple drugs with different mechanisms of action. This review examines novel therapeutic options that hold particular promise.
 
Metformin and B12 Deficiency » This complication affects about 30% of patients with diabetes who take metformin. Despite its common occurrence, vitamin B12 deficiency is often unrecognized and untreated. For this reason, patients on metformin should have their B12 level monitored annually. Published in BMJ. 2010;340:c2198
 
Origin Trial – NEJM 2012 – Outcome Reduction with an Initial Glargine Intervention » This large randomized prospective trial followed patients with prediabetes and diabetes who were on daily doses of basal insulin for 6 years. The study demonstrated that Lantus therapy had a neutral effect on cardiovascular outcomes and cancers.  And it reduced new onset diabetes in those with prediabetes.


Medications for Neuropathy

Painful Diabetic Neuropathy » scientific article that includes the latest research and medications that improve neuropathic pain. Also includes a step wise approach and dosing strategies for the different types of medications. Authored by Dr. Ziegler, Diabetes Care, 2009 32 (Supp 2).

 
Neuropathy Medications Summary Sheet » this “at a glance” summary page is designed to be a helpful tool to evaluate therapeutic improvements for your patients with diabetes neuropathy.  Authored by Beverly Thomassian.
 
 

Books and Study Tools

Upcoming Courses and Events

Upcoming Courses & Events

View Full Calendar

Latest Video

Watch Our Short “How-To” and Product Videos